29 C
Vientiane
Friday, May 2, 2025
spot_img
Home Blog Page 139

/C O R R E C T I O N — STRAVA, INC./

In the news release, Strava to Acquire Runna, A Leading Running Training App, issued 17-Apr-2025 by STRAVA, INC. over PR Newswire, we are advised by the company that in the “About Runna” section, the following should have been omitted: “or try out Runna with xCODE for 2 weeks of running coaching free today!” The complete, corrected release follows:

Strava to Acquire Runna, A Leading Running Training App

The world’s biggest team has a new coach

SAN FRANCISCO, April 17, 2025 /PRNewswire/ — Strava, the app for active people, today announced that it has entered into a definitive agreement to acquire Runna, a UK-headquartered tech company developing personalized running training plans and coaching. The acquisition unites the world’s largest fitness community with a leading app in the fiercely competitive running training space, creating compelling value for users and shareholders of both companies.

The world's biggest team is getting a new coach: Strava is acquiring Runna.
The world’s biggest team is getting a new coach: Strava is acquiring Runna.

“Coming off Strava’s accelerated innovation and unprecedented growth last year, it was the right time to look for complementary businesses that could create even greater value for our users,” said Michael Martin, chief executive officer, Strava. “Running is booming worldwide—nearly 1 billion runs were recorded on Strava in 2024. Runna’s mission to give every runner a personalized plan to achieve their goal is a perfect fit.”

According to Strava’s Year In Sport data, running is the fastest growing sport globally, and Gen Z in particular are turning to running to create community and connection. This has created a sharp increase in race participation, with 43% of Strava users wanting to conquer a big race or event in 2025. Demand for training plans has grown quickly as more athletes look for personalized guidance.

“We are delighted to become part of Strava as we continue to focus on bringing the world the most customized and personalized training plans available,” said Dom Maskell, co-founder and chief executive officer, Runna. “We have spent many hours together with Strava senior management and we couldn’t be more excited to be on the same team,” he added. “Our passion is to give every runner a training plan and access to amazing coaching and this investment allows us to make even more improvements to everything we do at Runna, benefiting runners worldwide” said Ben Parker, co-founder.

“I have been deeply impressed with Dom, Ben and the Runna team,” said Martin. “Our plan is to keep the apps separate for the foreseeable future, to invest in growing the Runna team and further accelerate the development of the Runna app.”

The deal is part of Strava’s ongoing initiatives to innovate for its 150+ million registered users and represents deep investment in Strava’s API developer community. Over 100 training apps currently connect to Strava’s API in order to provide users with enhanced features and functionality. Strava remains firmly committed to maintaining this role as the open platform for fitness and to supporting all developers, alongside Runna. “We are thrilled to have this opportunity to recognize and invest in an API developer like Runna,” said Martin. “Strava is the community for all active people regardless of sport, skill level, location, app or device.” 

The transaction is subject to customary closing conditions. Additional terms of the acquisition were not disclosed.

About Strava
Strava is the app for active people. With over 150 million athletes in more than 185 countries, it’s more than tracking workouts—it’s where people make progress together, from new habits to new personal bests. No matter your sport or how you track it, Strava’s got you covered. Find your crew, crush your goals, and make every effort count. Start your journey with Strava today.

Join the Strava Club or follow Strava on Instagram, X, Facebook, YouTube and LinkedIn.
Visit www.strava.com for more information.

About Runna 
Runna, one of the world’s top-rated running coaching apps on iOS and Android, was founded in 2021 by running enthusiasts Dom Maskell and Ben Parker. Officially launching in March 2022, the subscription-based app helped millions of runners complete their first race. Now available in over 180 countries, Runna was selected as one of three finalists for Apple’s App of the Year in 2024.

To learn more about the company and follow along on this amazing journey check out the latest by following us on Instagram, Reddit and LinkedIn.

Media Contact: 
press@strava.com

Photo – https://laotiantimes.com/wp-content/uploads/2025/04/strava___runna-1.jpg 

Discover a Taste of New Zealand from 17 April – 7 May 2025 at Cold Storage

Safe, Tasty, Premium, Nutritious, and Ethical — Experience New Zealand’s Treasured Flavours at Cold Storage & CS Fresh


SINGAPORE – Media OutReach Newswire – 17 April 2025 – From 17 April to 7 May, Singapore’s food lovers can journey through New Zealand’s magnificent landscapes featuring a wide range of safe, tasty, nutritious, ethical and premium quality food and beverage products through the “Discover a Taste of New Zealand” campaign. The 3-week promotion will take place across Cold Storage and CS Fresh’s 45 outlets, bringing the best of New Zealand’s food to Singapore shoppers.

New Zealand's Premium Products Are At Cold Storage from 17 April - 7 May 2025
New Zealand’s Premium Products Are At Cold Storage from 17 April – 7 May 2025

Some of the participating brands for this campaigns are: Anchor, Cookie Time, Meadow Fresh, Mother Earth, Otis, Rockit Apple, Tegel, Whittaker’s, Zespri, Zeagold available in Cold Storage and CS Fresh.

Beyond Cold Storage & CS Fresh, consumers can also explore products from Comvita (available in all Comvita x HoneyWorld stores), Nice & Natural (available on Lazada), Fourflax (available at Ace Asia Pet Care website) and K9 Natural (available at Kohepets).

The campaign was officially launched at Cold Storage Great World City, with a special Kapa Haka and waiata performance by students from the Australian International School. The powerful cultural showcase marked the opening of the campaign.

At the launch event, Maggie Christie, New Zealand’s Trade Commissioner to Singapore, noted that: “This year marks 60 years of diplomatic ties between New Zealand and Singapore—a milestone that speaks to the strength of our friendship, especially in trade and innovation. These products demonstrate our Māori value of Kaitiakitanga — caring for people, place, and planet, not just for now but for generations to come. Sustainability is at the heart, but they are also premium and delicious!”

The Secret Behind New Zealand’s Premium Food & Beverage

What makes New Zealand’s premium food particularly special for Singaporeans is how it transforms ordinary meals into extraordinary experiences. The butter that elevates morning toast, the Mānuka Honey collected from remote wilderness that boosts immunity, and the beautifully roasted meats for family dinner – these everyday luxuries showcase New Zealand’s commitment to bringing nature’s best to table.

As a world leader in premium food exports, New Zealand supplies 80% of its food to over 140 countries, with food and beverage products making up NZ$844 million of its total exports to Singapore in the year ending June 2024.

  • Standouts that make New Zealand food world-class – The clean air, lush pastures, fertile soils, and crystal-clear waters create the perfect conditions for producing food that is naturally nutritious and delicious.
  • The global recognition factor – New Zealand’s food products consistently win international awards for taste, quality, and sustainability.
  • From farm to fork: The journey of premium food – How New Zealand’s farmers and producers follow stringent quality control, ethical farming, and sustainability practices to ensure food safety and superior taste.
  • The Reasons Singaporean consumers should choose New Zealand products – From free-range poultry, grass-fed beef and lamb to GMO-free fruits, natural mānuka honeys, premium dairy and indulgent snacks, New Zealand offers food that’s healthier, fresher, and ethically sourced.

Personal Taste Journey Begins

The “Discover A Taste of New Zealand” fair invites Singaporeans to experience this premium food culture first-hand. Sample the differences that have earned global recognition and bring home a piece of New Zealand’s natural bounty to transform your own kitchen into a place where everyday meals become memorable occasions.

For a complete guide to this unique culinary event, including special promotions, visit https://www.nzmadewithcare.com/sg or your nearest Cold Storage & CS Fresh location.

Hashtag: #NZMadeWithCare #NewZealand #MadeWithCare




The issuer is solely responsible for the content of this announcement.

About Made with Care

The Made with Care initiative showcases New Zealand’s exceptional food and beverage sector—a testament to the country’s commitment to producing premium- quality products that respect both people and the planet. Led by New Zealand Trade & Enterprise (NZTE), this campaign connects discerning consumers worldwide with New Zealand’s finest producers.

In line with this global campaign, NZTE aims to expand the brand value of New Zealand products at a time when exporters are not able to be in-market. Since October 2020, a number of campaigns have been launched in major export markets. In Singapore, its partnership with Cold Storage & CS Fresh in the ‘Discover A Taste of New Zealand’ fair serves as an opportunity for consumers to learn more about the quality of New Zealand products.

Facebook:

About New Zealand Trade and Enterprise

Te Taurapa Tūhono | New Zealand Trade and Enterprise (NZTE) is the New Zealand government’s international business development agency. Our purpose is to grow companies internationally – bigger, better, faster – for the good of New Zealand. NZTE uses its extensive knowledge and global networks to help exporters of all sizes make better decisions and connect to the right partners and investors. We connect international businesses and investors with high-value growth opportunities in New Zealand.

ZTO Files Annual Report on Form 20-F for Fiscal Year 2024

SHANGHAI, April 17, 2025 /PRNewswire/ — ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading and fast-growing express delivery company in China (“ZTO” or the “Company”), today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (“SEC”) on April 17, 2025. The annual report on Form 20-F can be accessed on the Company’s investor relations website at http://zto.investorroom.com as well as the SEC’s website at http://www.sec.gov.

The Company will provide a hard copy of its annual report on Form 20-F containing the audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed to the Company’s IR Department at ir@zto.com.

The Company has also today published its annual report for the fiscal year ended December 31, 2024 pursuant to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (“SEHK”), which can be accessed on the Company’s investor relations website at http://zto.investorroom.com as well as the SEHK’s website at http://www.hkexnews.hk.

About ZTO Express (Cayman) Inc.

ZTO is a leading and fast-growing express delivery company in China. ZTO provides express delivery service as well as other value-added logistics services through its extensive and reliable nationwide network coverage in China.

ZTO operates a highly scalable network partner model, which the Company believes is best suited to support the significant growth of e-commerce in China. The Company leverages its network partners to provide pickup and last-mile delivery services, while controlling the mission-critical line-haul transportation and sorting network within the express delivery service value chain.

For more information, please visit http://zto.investorroom.com.

For investor and media inquiries, please contact:

ZTO Express (Cayman) Inc.

Investor Relations

E-mail: ir@zto.com
Phone: +86 21 5980 4508

Vipshop Filed 2024 Annual Report on Form 20-F

GUANGZHOU, China, April 17, 2025 /PRNewswire/ — Vipshop Holdings Limited (NYSE: VIPS), a leading online discount retailer for brands in China (“Vipshop” or the “Company”), today announced that the Company has filed its annual report on Form 20-F that includes its audited financial statements for three years ended December 31, 2024 with the U.S. Securities and Exchange Commission on April 17, 2025. The annual report is available on the Company’s website at ir.vip.com. Holders of the Company’s securities may request a copy of the Company’s annual report free of charge according to the instructions provided on the Company’s website.

About Vipshop Holdings Limited

Vipshop Holdings Limited is a leading online discount retailer for brands in China. Vipshop offers high quality and popular branded products to consumers throughout China at a significant discount to retail prices. Since it was founded in August 2008, the Company has rapidly built a sizeable and growing base of customers and brand partners. For more information, please visit https://ir.vip.com/.

Investor Relations Contact

Tel: +86 (20) 2233-0732
Email: IR@Vipshop.com 

 

Caliway Selected to Present CBL-514 Phase 2 Study Results for Dercum’s Disease at World Orphan Drug Congress USA 2025

  • CBL-514, Caliway’s novel small molecule drug, was selected for data presentation at the World Orphan Drug Congress USA 2025, highlighting its promising Phase 2 study results (CBL-0201DD) for Dercum’s Disease Treatment.
  • The Phase 2 topline results met all primary and secondary endpoints, with 64.5% of painful lipomas showing ≥ 50% dimension reduction or complete clearance (per-protocol population), and pain being reduced by 4.7 points (on a 10-point scale).
  • The program has advanced to a U.S. FDA-approved Phase 2b study (CBL-0202DD), with subject recruitment expected to be completed by Q3 2025, representing a potential breakthrough for patients with no approved treatment options.

TAIPEI, April 17, 2025 /PRNewswire/ — Caliway Biopharmaceuticals (TWSE: 6919) announced today that it has been invited to present the clinical results of its CBL-514 Phase 2 study (CBL-0201DD) in Dercum’s Disease at the upcoming World Orphan Drug Congress USA 2025, to be held in Boston on April 24, 2025.

CBL-514 is a novel 505(b)(1) small-molecule drug developed by Caliway. It has previously demonstrated promising results in the field of medical aesthetics. CBL-514 is also being investigated for Dercum’s Disease— a rare disease characterized by the growth of painful lipomas, with no approved treatment to date.

According to the CBL-0201DD Phase 2 study results, 64.5% of painful lipomas showed dimensions reduction of more than 50% or complete clearance after CBL-514 treatments, with more than half of painful lipomas achieved this outcome after only one CBL-514 treatment. The pain score was also reduced by 4.7 points (out of 10).

These results support CBL-514’s potential as a first-in-class treatment for Dercum’s disease, offering new hope to patients by significantly reducing lipoma size and pain.

The World Orphan Drug Congress USA is a leading global conference focused on rare disease and orphan drug development. Bringing together over 2,000 participants from academia, regulatory agencies, pharmaceutical and biotech companies, patient advocacy groups, and investors. The event serves as a key platform for advancing scientific innovation, regulatory policies, and access strategies in rare disease therapies.

Being selected to present at the most important event for all rare disease stakeholders, not only highlights the clinical potential of CBL-514 in rare disease treatment, but also underscores Caliway’s ongoing commitment to addressing unmet medical needs.

The drug has entered a U.S. FDA-approved Phase 2b clinical study (CBL-0202DD), which is currently ongoing and expected to complete patient recruitment by Q3 2025. If successful, CBL-514 could become the first approved treatment for Dercum’s Disease, offering a long-awaited therapeutic option for patients worldwide.

CBL-514 Study Presentation Info at World Orphan Drug Congress USA:

  • Conference: World Orphan Drug Congress USA 2025
  • Date & Time: April 24, 2025 (Thursday), 10:40 AM (Eastern Time)
  • Presentation Title: Efficacy and Safety of CBL-514, a Novel Lipolytic Injectable, in the Treatment of Dercum’s Disease: Phase 2 Study Results
  • Location: Boston Convention & Exhibition Center | Theater 2 – Hall C

For more details on the World Orphan Drug Congress USA 2025, please visit: the official website.

About Dercum’s Disease

Dercum’s disease is a rare disorder characterized by the development of painful lipomas primarily located on the trunk region, and the extremities close to the trunk. The pain is chronic (>3 months), symmetrical, often disabling, and resistant to traditional analgesics.

The etiology of Dercum’s disease remains unknown. There is no approved drug nor recommended standard treatment for Dercum’s disease yet. The current treatment options, including surgical removal, liposuction, electrotherapy, and inflammation inhibitors, are symptomatic, and the efficacies are limited with numerous adverse events. The clinical need for Dercum’s disease remains unmet.

According to the Global Dercum’s Disease Market Research Report, the global Dercum’s disease treatment market size in 2022 was $11.8 billion. With a compound annual growth rate (CAGR) of 6.76%, the global market of Dercum’s disease treatment in 2032 is estimated to expand to $22.7 billion.

About CBL-514

CBL-514, a 505(b)(1) and first-in-class small-molecule drug developed by Caliway, is the world’s first injectable lipolysis drug that induces adipocyte apoptosis to reduce subcutaneous fat in targeted areas without causing any systematic side effects on the central nervous system, cardiovascular system, and respiratory system. CBL-514 has demonstrated fewer side effects, superior efficacy, and fewer required treatments compared with existing surgical procedures and other non-invasive localized fat reduction solutions.

Caliway is currently investigating multiple indications for CBL-514, including non-surgical fat reduction, moderate-to-severe cellulite and weight rebound management. A derivative compound, CBL-514D, is being developed for indications including rare diseases such as Dercum’s disease and Obstructive Sleep Apnea (OSA). As of the end of November 2024, Caliway has enrolled a total of 520 subjects in clinical studies related to CBL-514. To date, 10 clinical studies have been completed with results available, and all these studies have met their primary efficacy endpoints and safety parameters. CBL-514 has demonstrated precise efficacy with a favorable safety profile across multiple indications, showing outstanding statistical significance (p<0.00001 or p<0.0001) in both ITT and FAS populations. Caliway plans to initiate subject recruitment for two pivotal global Phase 3 studies for localized fat reduction in the second half of 2025.

About Caliway Biopharmaceuticals

Caliway Biopharmaceuticals (Caliway) is a clinical-stage biopharmaceutical company driven to breakthrough drug discovery of novel small-molecule therapeutics. Listed on the Taiwan Exchange (TWSE-6919), Caliway aims to become an innovative pharmaceutical leader in aesthetic medicine and other diseases. For more information, please visit: https://www.caliway.com.tw/en

Disclaimer

This article and related information on this site contain forward-looking statements. The forward-looking information requires the Company to make numerous assumptions and is subject to inherent risks, uncertainties, and other factors that are beyond the control of the Company which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. The Company undertakes no obligation to timely inform, update, or revise the information on this site if circumstances should change.

HIKSEMI Unveils GEN5 SSD and Immersive Storage Solutions at the 137th Canton Fair

GUANGZHOU, China, April 17, 2025 /PRNewswire/ — HIKSEMI made a striking debut at the 137th Canton Fair, held from April 15th to 19th. Under the theme “Innovations Beyond Storage”, HIKSEMI showcased how cutting-edge technologies like PCIe 5.0 are breaking through traditional storage limitations to deliver faster, larger, and more powerful solutions that enhance everyday life and empower greater efficiency.


The highlight of the exhibition was the launch of the GEN5 SSD series, which boasts an impressive read speed of up to 14,500MB/s—twice that of the GEN4 SSD. This groundbreaking product has garnered significant attention for its ability to meet the demanding performance needs of applications such as gaming, entertainment, and content creation.


HIKSEMI curated seven immersive zones, blending technology into daily life and industry operations. Visitors explored intelligent document systems, cloud backup solutions, ultra-fast SSDs and DDR for 8K gaming, and professional-grade memory cards and portable drives designed for outdoor photography. Industrial showcases included secure data handling, stable storage for data centers, and high-concurrency processing for smart vehicles.

HIKSEMI introduced its branded IP mascot, Semi Elephant, to enhance audience interaction and engagement. Inspired by the saying that an elephant never forgets, the Semi Elephant symbolizes reliability, vast capacity, and enduring memory, highlighting HIKSEMI’s technical excellence while fostering emotional connections with consumers from diverse backgrounds.

Looking ahead, HIKSEMI remains committed to advancing storage technology, developing innovations, and expanding applications to enhance global user experiences.

OSL Powers Staking and Custody for ChinaAMC (HK)’s First Staking-Enabled Ether ETF

HONG KONG, April 17, 2025 /PRNewswire/ — OSL Digital Securities (OSL), a leading regulated digital asset platform and a member of OSL Group (863.HK), will provide staking services for the Ether assets of China Asset Management (Hong Kong)’s (ChinaAMC (HK)) Ether ETF (3046.HK / 83046.HK / 9046.HK), following formal approval from the Securities and Futures Commission of Hong Kong (SFC). Pioneering staking-as-a-service in a highly regulated environment, staking of ChinaAMC (HK)’s Ether assets via OSL may commence on 15 May 2025.

This is a groundbreaking evolution in the regulated digital asset landscape, enabling investors to participate in the Ethereum blockchain protocol’s proof-of-stake rewards mechanism through a tightly regulated and transparent platform. Staking of the ETF’s underlying Ether assets transforms the ETF from a passive investment product into an active participant in the Ethereum ecosystem while maintaining rigorous compliance standards.

Eugene Cheung, Chief Commercial Officer of OSL, emphasised the strategic importance of this milestone, “This landmark represents the maturing of crypto assets into an institutional-grade yield-generating product. As the regulated infrastructure provider enabling this functionality, OSL is proud to facilitate secure access to Ethereum’s native staking rewards while meeting the highest standards of investor protection. This achievement underscores Hong Kong’s leadership in developing sophisticated digital asset frameworks that bridge traditional and decentralised finance.”

Thomas Zhu, Head of Digital Assets and Family Office Business, ChinaAMC (HK), said, “Our collaboration with OSL to bring Ethereum staking capabilities to the ChinaAMC Ether ETF creates a secure, regulated gateway for investors of all types. By simplifying access to ETH staking, this service significantly lowers the threshold to participating in Ethereum staking, allowing both institutional and retail investors to easily contribute to network security while earning rewards. It also supports the broader growth of decentralized finance (DeFi), marking an important step forward for blockchain adoption in a regulated market.”

ChinaAMC (HK)’s Ether ETF, launched in April 2024 as part of Hong Kong’s first wave of spot crypto ETFs, with BOCI Prudential, serving as the primary custodian and fund administrator of the fund. OSL’s appointment as a staking infrastructure provider leverages the company’s comprehensive regulatory credentials, built upon OSL’s recent partnership with Kiln, the leading enterprise-grade staking platform. By combining Kiln’s institutional staking technology with OSL’s SFC-licensed platform, the collaboration delivers a fully compliant staking solution that meets the exacting requirements of ETF providers and institutional investors.

About OSL Hong Kong

As a subsidiary of the publicly listed OSL Group (HKEX: 863.HK), OSL Digital Securities is Hong Kong’s first and most established SFC-licensed and insured digital asset platform. Operating since 2018, the platform provides institutional-grade digital asset services to corporations, financial institutions, professional and retail investors.

OSL Hong Kong delivers services across five core domains: OTC brokerage, Omnibus broker solutions, custody, wealth management, and retail services. The OTC brokerage services provide 24/7 high-liquidity crypto trading with fiat on/off-ramp services. Custody solutions feature client-asset segregated wallet management backed by US$1 billion insurance coverage. The wealth management suite offers crypto investments to traditional investors, including tokenised treasuries, RWAs, structured crypto products, and quant investment strategies. Retail services bring institution-grade security and crypto access to professional and retail investors.

As a pioneer in bridging traditional finance and the digital asset economy, OSL Group adheres to its core concept:  Open, Secure, and Licensed, empowering the next generation of global financial infrastructure. In addition to Hong Kong (SAR), OSL Group expands operations under full regulatory compliance in Japan, Australia, Europe and beyond.

For more information, visit osl.com.

VinFast partners with Bengkel BOS to expand service workshop network in Indonesia


HANOI, VIETNAM – Media OutReach Newswire – 17 April 2025 – VinFast has announced a new partnership with PT Penta Artha Impressi (Bengkel BOS), an Indonesian service provider, aimed at improving customer service and maximizing benefits for those transitioning to electric vehicles. This move is part of VinFast’s strategy to expand its sales and after-sales network as its electric vehicle product line grows in Indonesia.

Mr. Mochamad Agus Rijadi (left), Director of Aftersales at VinFast Indonesia, and Mr. Endro Arifin, President Director of PT Penta Artha Impressi (Bengkel BOS), at the MOU signing ceremony.
Mr. Mochamad Agus Rijadi (left), Director of Aftersales at VinFast Indonesia, and Mr. Endro Arifin, President Director of PT Penta Artha Impressi (Bengkel BOS), at the MOU signing ceremony.

Under the agreement, 12 service workshops of PT Penta Artha Impressi (Bengkel BOS) will be authorized to provide repair, warranty, and maintenance services for VinFast’s electric vehicle models. This network of service workshops is strategically located across key areas such as South Jakarta, West Jakarta, East Jakarta, Tangerang, and Yogyakarta, aiming to maximize convenience for customers.

The maintenance, repair, and warranty services provided by Bengkel BOS will conform to VinFast’s quality standards and procedures. This network of service centers is fully equipped with modern facilities, machinery, and equipment, meeting strict technical requirements.

As a strategic authorized service partner, Bengkel BOS will also distribute genuine VinFast parts and components, ensuring that electric vehicle users in Indonesia have access to high-quality products that adhere to VinFast’s global standards.

Throughout the partnership, VinFast is committed to providing personnel training and technical advisory support to Bengkel BOS. This is particularly crucial as VinFast’s electric vehicle product line expands in Indonesia and the number of vehicle deliveries is projected to increase.

Mr. Endro Arifin, President Director at PT Penta Artha Impressi (Bengkel BOS), stated: “Leveraging our experience, local expertise, and extensive service workshop network, we are honored to become a strategic partner of VinFast on its journey to conquer the Indonesian market. Together, Bengkel BOS and VinFast are committed to delivering exceptional experiences to consumers while contributing to the continuous development of the region’s electric vehicle market.”

Mr. Pham Sanh Chau, CEO of VinFast Asia, stated, To accelerate the green transition in Indonesia, we believe that building strong, long-term customer trust is paramount. To achieve this, VinFast actively collaborates with reputable partners to expand our network of authorized service workshops in Indonesia. We remain steadfast in our commitment to the three core pillars that have defined the VinFast brand: high-quality products, inclusive pricing, and outstanding after-sales service.

VinFast offers one of the market’s most diverse portfolios of all-electric vehicles, ranging from the mini-SUV VF 3 and the A-segment SUV VF 5 to the C-segment SUV VF e34. In parallel with its continuously expanding product ecosystem, VinFast is broadening its network of dealerships and service workshops nationwide, aiming to deliver high-quality products and services to consumers.

Concurrently, VinFast is cultivating a comprehensive green mobility ecosystem through strategic collaborations with key partners, including the all-electric taxi operator GSM and the global charging infrastructure developer V-GREEN.

Hashtag: #VinFast

The issuer is solely responsible for the content of this announcement.

About VinFast

VinFast (NASDAQ: VFS), a subsidiary of Vingroup JSC, one of Vietnam’s largest conglomerates, is a pure-play electric vehicle (“EV”) manufacturer with the mission of making EVs accessible to everyone. VinFast’s product lineup today includes a wide range of electric SUVs, e-scooters, and e-buses. VinFast is currently embarking on its next growth phase through rapid expansion of its distribution and dealership network globally and increasing its manufacturing capacities with a focus on key markets across North America, Europe and Asia. Learn more at

About PT Penta Artha Impressi (Bengkel BOS)

Bengkel BOS operates 29 high-standard car workshops, prioritizing its business in tyres, oils, spare parts, and car services. In addition, the services are supported by professional technicians and the latest technology. Bengkel BOS is committed to providing excellent service for customers and becoming a leading network of digital automotive workshops. Learn more at: